- Design
- Systematic review and meta-analysis of seven observational studies
- Population
- 7,887 patients with type 2 diabetes after ACS or PCI
- Primary outcome
- Recurrent MI and repeat coronary revascularisation
- Effect
- Recurrent MI HR 2.17 (95% CI 1.02–4.62, I² 75%); repeat revascularisation HR 1.68 (0.79–3.57)
A meta-analysis pooled seven observational studies of 7,887 patients with type 2 diabetes who had an acute coronary syndrome or PCI.
Raised lipoprotein(a) was associated with recurrent myocardial infarction (pooled HR 2.17, 95% CI 1.02–4.62), but heterogeneity was high (I² 75%) and the lower confidence limit sits just above 1. It was not clearly associated with repeat revascularisation (HR 1.68, 0.79–3.57).
There is still no licensed therapy that lowers Lp(a) with proven outcome benefit, so the value of knowing it lies in risk stratification: a high level is a reason to push every other modifiable factor harder — LDL cholesterol, blood pressure, glycaemia, smoking.
Lp(a) levels are largely genetic and are often high in South Asian populations, which makes a single measurement after a coronary event particularly informative in Indian practice.
- Consider measuring Lp(a) once in patients with diabetes after an acute coronary syndrome
- Treat a high Lp(a) as a reason to intensify LDL lowering and other risk-factor control
- Record the value in the notes — it barely changes over life, so it rarely needs repeating
- Do not expect statins to lower Lp(a); they can raise it slightly
Why it matters
Residual risk in diabetic ACS survivors may be partly inherited and invisible on a standard lipid panel.
Don't overread it
These are observational associations with high heterogeneity; they do not show that lowering Lp(a) prevents MI.
The statistics, in plain English
A hazard ratio of 2.17 suggests about twice the rate of recurrent MI. The confidence interval runs from 1.02 to 4.62, so the true effect could be barely above none or more than quadruple. An I² of 75% means the seven studies disagreed considerably.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for cardiology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free